Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

UK chief pharmaceutical officers back RPS royal college proposals

The four officers have “strongly encouraged” Society members to vote in favour of a Royal College of Pharmacy, as the ballot on the decision opens.…

PDA to recommend a ‘no’ vote to RPS royal college proposals unless current ballot is cancelled

The Pharmacists’ Defence Association has said the vote should be delayed to allow proposals “to be reconsidered and amended where necessary”.…

Alzheimer’s treatments donanemab and lecanemab still not recommended under latest NICE draft guidance

NICE says that the cost of implementing donanemab and lecanemab across the NHS is “significantly higher” than considered acceptable for taxpayers’ money and NHS resources.…

Fewer people reporting problems obtaining prescriptions in England, show ONS data

Survey results have revealed that 88.1% of patients said they experienced no issues accessing medicines from their pharmacy in January 2025, compared with 79.9% in August 2024.…

Rapid on-site genetic sequencing could help curb antimicrobial-resistant outbreaks, says MHRA

Researchers found that rapid on-site genetic sequencing detects bacterial infections within two days, which is “significantly faster“ than traditional methods.…

Standard-dose DOACs not necessarily better than reduced dose, study results suggest

Researchers found that “non-inferiority” of a reduced dose of direct oral anticoagulants could not be determined when compared with a standard dose, with “reliably low rates” of recurrent venous thromboembolism.…

Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows

The model was also associated with a 38% reduction in the likelihood of glycaemic failure over five years.…

SIGN rejects opioids and medicinal cannabis for chronic pain in draft guidance

Draft guidance on management of chronic pain included medicinal cannabis for the first time, not recommending it on the basis of limited clinical evidence and consistent evidence of adverse effects.…

Nine in ten people would accept a pharmacogenomics test, reveals survey

The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…

David Taylor (1946–2025)

Lauded as an “instrumental” figure in UK pharmacy by his peers, David Taylor held a broad range of influential teaching and public health policy roles during his career.…